Progress Complication

Sponsor
Minneapolis Heart Institute Foundation (Other)
Overall Status
Recruiting
CT.gov ID
NCT05100940
Collaborator
(none)
4,000
1
121.2
33

Study Details

Study Description

Brief Summary

Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center observational registry are to examine frequency of complications occuring during cardiac catheterization and PCI, examine procedural strategies utilized for complication management, and evaluate the clinical outcomes (both immediate and during follow-up.)

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cardiac Catheterization

Detailed Description

The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. Systematic study of cardiac procedure complications can improve procedural safety and optimize short and long-term patient outcomes. The objectives of this multi-center observational registry are to

1-Examine the frequency and types of complications occurring during cardiac catheterization and PCI among participating sites, 2-Examine the procedural strategies (techniques and devices) utilized for complication management, 3-Evaluate the clinical outcomes (both immediate and during follow-up) after each complication type.

Study Design

Study Type:
Observational
Anticipated Enrollment :
4000 participants
Observational Model:
Case-Only
Time Perspective:
Other
Official Title:
Prospective Global Registry of Complications of Percutaneous Coronary Interventions
Actual Study Start Date :
Nov 24, 2020
Anticipated Primary Completion Date :
Dec 31, 2030
Anticipated Study Completion Date :
Dec 31, 2030

Outcome Measures

Primary Outcome Measures

  1. in-hospital major cardiac adverse events (MACE) [From Date of Procedure to Date of Hospital Discharge, approximately 48-72 hrs after index procedure]

    including any of the following adverse events prior to hospital discharge: death, stroke, myocardial infarction, recurrent angina requiring urgent repeat target vessel revascularization with PCI or coronary bypass surgery, and tamponade requiring pericardiocentesis or surgery.

  2. Technical Success of PCI [From Date of Procedure to Date of Hospital Discharge, approximately 48-72 hrs after index procedure]

    Technical success of PCI will be defined as successful lesion recanalization by any method with achievement of < 30% residual stenosis and TIMI 3 flow in both the main vessel and side branch. discharge: death, stroke, myocardial infarction, recurrent angina requiring urgent repeat target vessel revascularization with PCI or coronary bypass surgery, tamponade requiring pericardiocentesis or surgery); technical and procedural success; contrast volume, procedure time, fluoroscopy time, air kerma radiation dose.

  3. Procedural success of PCI [From Date of Procedure to Date of Hospital Discharge, approximately 48-72 hrs after index procedure]

    Procedural success of PCI will be defined as achievement of technical success and with no in-hospital major adverse cardiac events (MACE).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
  • Over 18 years of age

  • undergoing coronary angiography or PCI

  • A complication occurred during or after the procedure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Minneapolis Heart Institute Foundation Minneapolis Minnesota United States 55407

Sponsors and Collaborators

  • Minneapolis Heart Institute Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Minneapolis Heart Institute Foundation
ClinicalTrials.gov Identifier:
NCT05100940
Other Study ID Numbers:
  • PROGRESS-COMPLICATION
First Posted:
Oct 29, 2021
Last Update Posted:
Oct 29, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Minneapolis Heart Institute Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 29, 2021